Strategic growth BR&B operates in securities litigation with a history of pioneering actions and high-stakes wins, signaling potential for premium, complex matters where institutional investors require experienced representation.

Expansion signals Recent activity includes active litigation in 2026 such as the GeneDx suit, suggesting openness to new matters, healthcare and biotech securities actions, and opportunities to engage on emerging cases.

Tech leverage BR&B has invested in BEAMS, a web-based evaluation and monitoring system for institutional investors, indicating a willingness to adopt client-facing technology that can streamline matter intake and client reporting.

Financial capacity Revenue range indicates a mid-market firm with room to scale; target clients include large pension funds and institutional investors seeking experienced plaintiffs’ counsel in complex securities actions.

Market positioning With a long track record dating to 1976 and a reputation for landmark PSLRA leadership and multi-billion dollar recoveries, BR&B presents a compelling value proposition for plaintiffs needing proven securities litigation expertise.